| Line Item | 2025-12-29 | Y/Y |
|---|---|---|
| Revenue | $2.91B | +19.0% |
| Cost of Revenue | $2.30B | +17.3% |
| Gross Profit | $601.7M | +26.0% |
| R&D Expense | $29.0M | -9.0% |
| SG&A Expense | $192.1M | +13.0% |
| Operating Income | $264.7M | +128.1% |
| Pre-tax Income | $210.3M | +150.6% |
| Income Tax | $32.9M | +18.9% |
| Net Income | $177.4M |
| Line Item | 2025-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $501.2M | -0.5% |
| Accounts Receivable | $563.7M | +25.7% |
| Inventory | $250.1M | +11.1% |
| Current Assets | $1.86B | +15.5% |
| Total Assets | $3.84B | +10.6% |
| Current Liabilities | $962.2M | +18.9% |
| Long-term Debt | $916.2M | -0.2% |
| Line Item | 2025-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $291.9M | +23.2% |
| Capital Expenditures | $292.6M | +57.5% |
| Investing Cash Flow | -$273.9M | -87.4% |
| Financing Cash Flow | -$20.9M | +43.2% |
| Free Cash Flow | -$683K | -101.3% |
| +215.2% |
| EPS (Basic) | $1.73 | +214.5% |
| EPS (Diluted) | $1.68 | +211.1% |
| Stockholders' Equity |
| $1.76B |
| +12.7% |